Healionics Corporation, a start-up biomaterials company in Redmond, announced the sale and shipment of the first commercial product featuring Healionics’ STAR® biomaterial. A company press release says the product, TR-ClarifEYE™, an innovative veterinary glaucoma implant marketed by TR BioSurgical, LLC (TRBIO), is scheduled for limited market launch in April 2009. “We are very excited to announce the first commercial shipment of STAR, which is a significant milestone for Healionics and represents the Company’s first revenue from product sales,” said Healionics CEO Michel Alvarez. In related news, Alvarez replaces Rob Brown as CEO in a management change.
Related external links (will open a new window):
Related WTC links: